Defunct Company
Total Trials
10
As Lead Sponsor
9
As Collaborator
1
Total Enrollment
2,942
NCT01846442
Topical DHEA Against Vaginal Atrophy
Phase: Phase 3
Role: Lead Sponsor
Start: Jun 30, 2007
Completion: Oct 31, 2008
NCT01256671
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
Start: Dec 31, 2010
Completion: Dec 31, 2012
NCT01256684
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
Completion: Nov 30, 2011
NCT01358760
Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy
Start: Jun 30, 2011
Completion: May 31, 2012
NCT01452373
Dehydroepiandrosterone (DHEA) + Acolbifene Against Vasomotor Symptoms (Hot Flushes) in Postmenopausal Women
Start: Oct 31, 2011
Completion: May 31, 2013
NCT02013544
Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause
Start: Feb 28, 2014
Completion: Feb 28, 2015
NCT03287232
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Start: Oct 16, 2017
Completion: Jul 22, 2019
NCT03740945
Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer
Start: Nov 6, 2018
Completion: Dec 5, 2019
NCT03619005
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study
Start: Nov 13, 2018
Completion: Dec 6, 2019
NCT03782480
Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy
Role: Collaborator
Start: Mar 2, 2019
Completion: Jan 2, 2021